Vigil Neuroscience Stock Market Value
VIGL Stock | USD 3.05 0.01 0.33% |
Symbol | Vigil |
Vigil Neuroscience Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.07) | Return On Assets (0.40) | Return On Equity (0.70) |
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vigil Neuroscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vigil Neuroscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vigil Neuroscience.
10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Vigil Neuroscience on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Vigil Neuroscience or generate 0.0% return on investment in Vigil Neuroscience over 30 days. Vigil Neuroscience is related to or competes with Molecular Partners, Pmv Pharmaceuticals, Monte Rosa, Entrada Therapeutics, Third Harmonic, Cullinan Oncology, and Edgewise Therapeutics. Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for ... More
Vigil Neuroscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vigil Neuroscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vigil Neuroscience upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.08) | |||
Maximum Drawdown | 19.63 | |||
Value At Risk | (6.30) | |||
Potential Upside | 5.29 |
Vigil Neuroscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vigil Neuroscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vigil Neuroscience's standard deviation. In reality, there are many statistical measures that can use Vigil Neuroscience historical prices to predict the future Vigil Neuroscience's volatility.Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.11) | |||
Total Risk Alpha | (0.66) | |||
Treynor Ratio | 0.2583 |
Vigil Neuroscience Backtested Returns
Vigil Neuroscience owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0405, which indicates the firm had a -0.0405% return per unit of risk over the last 3 months. Vigil Neuroscience exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vigil Neuroscience's Variance of 13.41, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,180) to confirm the risk estimate we provide. The entity has a beta of -0.69, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Vigil Neuroscience are expected to decrease at a much lower rate. During the bear market, Vigil Neuroscience is likely to outperform the market. At this point, Vigil Neuroscience has a negative expected return of -0.15%. Please make sure to validate Vigil Neuroscience's value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if Vigil Neuroscience performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.61 |
Very good reverse predictability
Vigil Neuroscience has very good reverse predictability. Overlapping area represents the amount of predictability between Vigil Neuroscience time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vigil Neuroscience price movement. The serial correlation of -0.61 indicates that roughly 61.0% of current Vigil Neuroscience price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.61 | |
Spearman Rank Test | -0.61 | |
Residual Average | 0.0 | |
Price Variance | 0.07 |
Vigil Neuroscience lagged returns against current returns
Autocorrelation, which is Vigil Neuroscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vigil Neuroscience's stock expected returns. We can calculate the autocorrelation of Vigil Neuroscience returns to help us make a trade decision. For example, suppose you find that Vigil Neuroscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Vigil Neuroscience regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vigil Neuroscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vigil Neuroscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vigil Neuroscience stock over time.
Current vs Lagged Prices |
Timeline |
Vigil Neuroscience Lagged Returns
When evaluating Vigil Neuroscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vigil Neuroscience stock have on its future price. Vigil Neuroscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vigil Neuroscience autocorrelation shows the relationship between Vigil Neuroscience stock current value and its past values and can show if there is a momentum factor associated with investing in Vigil Neuroscience.
Regressed Prices |
Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Vigil Neuroscience Correlation, Vigil Neuroscience Volatility and Vigil Neuroscience Alpha and Beta module to complement your research on Vigil Neuroscience. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Vigil Neuroscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.